NEJM· Shun Lu Nicolas Girard James Chih-Hsin Yang Frances A. Shepherd Xiaorong Dong Surein Arulananda Giulio Metro Hidetoshi Hayashi Laura Bonanno Yu Jung Kim Zhe Liu Myung-Ju Ahn Yuping Sun Thuong Vu Le Silvia Novello Sang-We Kim Yanqiu Zhao Phuong Nguyen Mariana Brandão Yongsheng Wang Missak Haigentz Daniel Misch Mariano Provencio Pulla Wen-Tsung Huang Clarissa Baldotto Marcelo Tatangelo Colin R. Lindsay Ryan J. Hartmaier Rafal Lolo Balakumar Swaminathan Alexander Gont Francis Maria Esposito and Yusuke Okumathe SAFFRON Investigators*·· 24 天前精选AI 评分60
奥希替尼联合赛沃替尼用于EGFR-TKI治疗进展后的晚期NSCLC
Osimertinib–Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy
AI 导读
NEJM 刊发 SAFFRON 研究结果,评估奥希替尼联合赛沃替尼在 EGFR-TKI 治疗期间进展的晚期非小细胞肺癌患者中的疗效。目前仅有在线先发(Ahead of Print)信息,具体数据尚未在摘要中披露。
来源:NEJM · nejm.org